Skip Navigation

Microbiome in immunotherapy na�ve NSCLC patients receiving PD-1/L1 blockade MIP_NSCLC

Brief Summary

Type:
Lung Cancers

Study Type:
Basic Science

Phase:
IV

ClinicalTrials.gov Identifier:
NCT04636775

Study #:
STUDY00146102

Start Date:
Jul 29, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04636775

View Complete Trial Details & Eligibility at ClinicalTrials.gov